C4 Therapeutics (CCCC)
(Delayed Data from NSDQ)
$6.50 USD
+0.06 (0.93%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $6.49 -0.01 (-0.15%) 6:20 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Earnings News For CCCC
-
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
-
C4 Therapeutics, Inc. (CCCC) Reports Q4 Loss, Misses Revenue Estimates
-
C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
-
C4 Therapeutics (CCCC) to Report Q4 Earnings: What's in Store?
-
C4 Therapeutics, Inc. (CCCC) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
-
C4 Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
-
C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Lags Revenue Estimates
-
C4 Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
-
C4 Therapeutics, Inc. (CCCC) Reports Q1 Loss, Lags Revenue Estimates
-
C4 Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
-
C4 Therapeutics, Inc. (CCCC) Reports Q4 Loss, Lags Revenue Estimates
-
C4 Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights
-
C4 Therapeutics, Inc. (CCCC) Reports Q3 Loss, Lags Revenue Estimates
-
C4 Therapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights
-
C4 Therapeutics, Inc. (CCCC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Tops Revenue Estimates
-
C4 Therapeutics, Inc. (CCCC) Reports Q1 Loss, Lags Revenue Estimates